Exscalate4Cov

European project that aims to leverage supercomputers and in-silico drug design for urgent computing scenarios such as pandemics
Thing Covid 19 Drug Repurposing Research Q111165024

Facts

6 properties
Official website
www.exscalate4cov.eu[6]
Budget
2,970,875 EUR[7]
End time
September 30, 2021[5]
Start time
April 1, 2020[4]
🏷️ Also known as
en E4C en Exscalate4Cov it E4C
🔖 Identifiers · 2
Image (Wikimedia Commons)
Exscalate4cov.png ↗

Report an error or request removal Lineage (PROV-JSON)

Press Enter · cited answer in seconds

Summary

Exscalate4Cov is a COVID-19 drug repurposing research[1].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Exscalate4Cov. Retrieved November 11, 2026, from https://4ort.xyz/entity/exscalate4cov
MLA “Exscalate4Cov.” 4ort.xyz Knowledge Graph, 4ort.xyz, 11 Nov. 2026, https://4ort.xyz/entity/exscalate4cov.
BibTeX @misc{4ortxyz_exscalate4cov_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Exscalate4Cov}}, year = {2026}, url = {https://4ort.xyz/entity/exscalate4cov}, note = {Accessed: 2026-11-11}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Exscalate4Cov — https://4ort.xyz/entity/exscalate4cov (retrieved 2026-11-11)

Canonical URL: https://4ort.xyz/entity/exscalate4cov · Last refreshed: